Showing results (151-160 of 5,644) with videos related to

Sort By:
Pageof 565
Drug Design, Development and Therapy|June 22, 2018
Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysisDan Liu, Xiaodan Li, Yonggang Zhang, et al.
Drug Design, Development and Therapy|October 1, 2019
The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult maleDasohm Kim, Min Soo Park, Byung Won Yoo, et al.
Drug Design, Development and Therapy|October 1, 2019
Omalizumab for chronic spontaneous urticaria in "complex" patients: data from real-life clinical practiceLaura Vollono, Arianna Piccolo, Caterina Lanna, et al.
Drug Design, Development and Therapy|October 1, 2019
Clinical evaluation of dacomitinib for the treatment of metastatic non-small cell lung cancer (NSCLC): current perspectivesDaniele Lavacchi, Francesca Mazzoni, Giuseppe Giaccone
Drug Design, Development and Therapy|October 2, 2019
Identification of substandard drug products using electronic tongue: cefdinir suspension as a pilot exampleNawaf Abu-Khalaf, Abdel Naser Zaid, Nidal Jaradat, et al.
Drug Design, Development and Therapy|October 2, 2019
A novel curcumin-loaded composite dressing facilitates wound healing due to its natural antioxidant effectYong Zhao, Chuanyu Dai, Zheng Wang, et al.
Drug Design, Development and Therapy|October 2, 2019
Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed ConditionsLihua Wu, Chang Xu, Guolan Wu, et al.
Drug Design, Development and Therapy|March 31, 2017
Artonin E induces p53-independent G1 cell cycle arrest and apoptosis through ROS-mediated mitochondrial pathway and livin suppression in MCF-7 cellsImaobong Christopher Etti, Abdullah Rasedee, Najihah Mohd Hashim, et al.
Drug Design, Development and Therapy|April 1, 2017
Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysisRuili Yu, Bo Yang, Xiaohua Chi, et al.
Drug Design, Development and Therapy|March 14, 2019
siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivoFang Li, ZhiHan Zhu, Man Xue, et al.
Pageof 565